Advisors' Inner Circle Fund II held total net Assets of $18,195,021.56 as of 2026-06-30, with Galderma Group AG its largest holding at 7.287662867710%. Those weights show portfolio exposure concentrated across Galderma, TSMC, NVIDIA and Alphabet, while the fund also held $40,429.35 in cash sweep interest.
Key Highlights
- Cash sweep interest totalled $40,429.35000000 in U.S. dollars.
- Spot FX contracts covered CHF/USD, EUR/USD and SEK/USD, with settlement on 2026-07-01.
- The filing listed common stock holdings, cash sweep interest and spot FX contracts.
Advisors' Inner Circle Fund II held total net assets of $18,195,021.56 ($18.2 million) as of 2026-06-30.
Portfolio Structure Listed
The filing listed common stock holdings. It also included cash sweep interest and spot FX contracts.
Cash sweep interest held in U.S. dollars amounted to $40,429.35000000. The portfolio included spot contracts for CHF/USD, EUR/USD and SEK/USD.
July FX Settlements
The spot FX contracts were listed with settlement on 2026-07-01. The filing identified the contracts as CHF/USD, EUR/USD and SEK/USD.
FAQs
Q: What were Advisors' Inner Circle Fund II’s total net assets?
A: Advisors' Inner Circle Fund II reported total net assets of $18,195,021.56 as of 2026-06-30. The filing reported the amount for the portfolio dated 2026-06-30.
Q: Which stocks were the largest Advisors' Inner Circle Fund II holdings?
A: Galderma Group AG was the largest disclosed stock position at $1,325,991.83. Taiwan Semiconductor Manufacturing Company Limited, NVIDIA CORPORATION, ALPHABET INC. And Sandvik Aktiebolag followed among the top positions.
Q: What currencies did the fund’s spot FX contracts cover?
A: Advisors' Inner Circle Fund II listed spot FX contracts for CHF/USD, EUR/USD and SEK/USD. The contracts carried a settlement date of 2026-07-01.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.